Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention | Zendy

Stephan Windecker | Zendy; Renato D. Lópes | Zendy; Tyler Massaro | Zendy; Charlotte Jones-Burton | Zendy; Christopher B. Granger | Zendy; Ronald Aronson | Zendy; Gretchen Heizer | Zendy; Shaun G. Goodman | Zendy; Harald Darius | Zendy; W. Schuyler Jones | Zendy; Michael Aschermann | Zendy; David Brieger | Zendy; Fernando Cura | Zendy; Thomas Engstrøm | Zendy; Viliam Fridrich | Zendy; Sigrun Halvorsen | Zendy; Kurt Huber | Zendy; HyunJae Kang | Zendy; José L. Leiva-Pons | Zendy; Basil S. Lewis | Zendy; Germán Málaga | Zendy; Nicolas Méneveau | Zendy; Béla Merkely | Zendy; Davor Miličić | Zendy; João Morais | Zendy; Tatjana Potpara | Zendy; Dimitar Raev | Zendy; Manel Sabaté | Zendy; Suzanne de WahaThiele | Zendy; Robert C. Welsh | Zendy; Denis Xavier | Zendy; Roxana Mehran | Zendy; John H. Alexander | Zendy

Open Access

Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention

Author(s) -

Stephan Windecker,

Renato D. Lópes,

Tyler Massaro,

Charlotte Jones-Burton,

Christopher B. Granger,

Ronald Aronson,

Gretchen Heizer,

Shaun G. Goodman,

Harald Darius,

W. Schuyler Jones,

Michael Aschermann,

David Brieger,

Fernando Cura,

Thomas Engstrøm,

Viliam Fridrich,

Sigrun Halvorsen,

Kurt Huber,

HyunJae Kang,

José L. Leiva-Pons,

Basil S. Lewis,

Germán Málaga,

Nicolas Méneveau,

Béla Merkely,

Davor Miličić,

João Morais,

Tatjana Potpara,

Dimitar Raev,

Manel Sabaté,

Suzanne de WahaThiele,

Robert C. Welsh,

Denis Xavier,

Roxana Mehran,

John H. Alexander

Publication year - 2019

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.119.043308

Subject(s) - medicine , conventional pci , percutaneous coronary intervention , acute coronary syndrome , atrial fibrillation , apixaban , cardiology , aspirin , vitamin k antagonist , antithrombotic , warfarin , myocardial infarction , rivaroxaban

The safety and efficacy of antithrombotic regimens may differ between patients with atrial fibrillation who have acute coronary syndromes (ACS), treated medically or with percutaneous coronary intervention (PCI), and those undergoing elective PCI.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research